findmyKOL
Clinical trialNCT01276236CompletedPhase 2Interventional

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

SponsorUniversity of California, San FranciscoEnrollment13Kaposi's Sarcoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this pilot study is to determine whether Maraviroc is effective in the treatment of Kaposi's Sarcoma (KS), when it does not remit with standard antiretroviral drug therapy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Patrick Unemori, MD

    University of California, San Francisco; San Francisco General Hospital (SFGH)

    Principal Investigator
    clinicaltrials.gov ↗
  • Toby Maurer, MD

    University of California, San Francisco; San Francisco General Hospital (SFGH)

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Francisco General Hospital, Clinical Trials Unit

    San Francisco, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Maraviroc →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Mar 2011
Primary completion
31 Jan 2015
Completion
30 Apr 2015
Last update posted
5 Mar 2021
Registered enrollment
13
Registry id
NCT01276236
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.